Searchers often ask whether peptides are a steroid-free alternative. The question mixes four things that regulators and papers can answer separately: what the compounds are, how the law treats them, what anti-doping rules say, and what trials and safety reviews report. We read the statute, the schedules, two anti-doping pages and the studies. This is a comparison and not advice to use either, and research peptides are sold for laboratory use only.
What each one is
US law defines an anabolic steroid as a drug or hormonal substance chemically and pharmacologically related to testosterone that promotes muscle growth or has testosterone-like effects. A peptide is a short chain of amino acids, which our guide to what a peptide is explains. The word describes a chemical form and not a mechanism or a safety grade. The tesamorelin label says it binds growth hormone releasing factor receptors and stimulates the pituitary to release the body's own growth hormone. Other compounds we cover work differently, as our posts on IGF-1 LR3 and myostatin inhibitors show.
Side by side
Swipe the table sideways to see every column.
| Question | Anabolic steroids | The peptides we cover |
|---|---|---|
| US controlled substance schedule | Schedule III, with the substances listed in 21 CFR 1308.13(f) | We searched the text of 21 CFR Part 1308 for ipamorelin, sermorelin, tesamorelin, CJC-1295, ibutamoren, follistatin and growth hormone and found none of them. |
| Anti-doping list | Category S1. The Cologne laboratory says steroids were first banned in 1974 and testosterone in 1984. | Mostly category S2, plus S4 for myostatin inhibitors. See our posts on the pair, IGF-1 LR3 and myostatin. |
| Clearest muscle trial we found | A randomized trial of testosterone in 43 normal men over 10 weeks: more muscle size and strength than placebo, and more again with training. | Little. One 2008 trial of MK-677, which is not a peptide, in 65 older adults measured fat-free mass and saw no change in strength. |
| Health-risk record | A 2014 Endocrine Society statement links performance-enhancing drug use to a higher risk of death and a wide range of heart, mental health, metabolic, hormone, liver and kidney disorders. | Safety data are limited. A 2026 review calls them experimental with poorly defined long-term risks, and the FDA records safety concerns for ipamorelin and CJC-1295. |
Not scheduled does not mean approved
The compounds in our posts do not appear in the controlled substance schedules we searched. That is a statement about the schedules and not about approval. The FDA's page on bulk substances that may pose significant safety risks, current as of 22 April 2026, lists ipamorelin in category 2, records safety concerns for CJC-1295, and places ibutamoren in category 2. Our guide to research-use-only labeling explains what that label does and does not cover. We give no legal advice.
Which has better evidence
For muscle, the steroid has the clearer randomized trial. The 1996 testosterone trial opens by saying athletes use androgenic steroids even though efficacy was unsubstantiated, and then reports gains in muscle size and strength over placebo. The peptides we cover mostly have trials of hormone levels, a few small lean mass results, and animal work, as our posts on the best peptides for muscle growth and on what trials measured for muscle gain set out.
Clearer evidence of an effect is not evidence of safety. The Endocrine Society statement says there is a widespread misperception that performance-enhancing drug use is safe or that its effects are manageable, and that most users are non-athlete weightlifters. It adds that users often take doses far above normal and combine drugs, which trials cannot ethically copy.
The safer-alternative claim
A 2026 critical review says peptides are marketed as more selective and ostensibly safer alternatives to steroids. It concludes that they remain experimental substances with poorly defined long-term risks, and that the supply chain is largely unregulated, with products often mislabeled or contaminated. We found no source that shows peptides are safer than steroids, and the 2026 review calls peptide use in sport high risk. The evidence on both sides is uneven, and the peptide side has the thinner safety record.
Frequently asked questions
Are peptides steroids?
No. US law defines anabolic steroids as substances related to testosterone. Peptides are chains of amino acids, and the compounds we cover act on different targets, such as the growth hormone releasing receptor.
Are peptides controlled substances?
We found none of the compounds in our posts in the federal schedules we searched. That is not an approval, and the FDA has flagged safety concerns for some. This site gives no legal advice.
Are peptides safer than steroids?
We found no source that shows it. A 2026 review calls them experimental with poorly defined long-term risks, and the Endocrine Society says the harms of performance drugs are underappreciated.